Pharmena S.A. (WAR:PHR) — Stock Price

zł3.07 PLN
▲ 0.33% today

Pharmena S.A. (WAR:PHR) is currently trading at zł3.07 PLN, up 0.33% today. Over the past 52 weeks, shares have ranged between zł2.55 and zł4.22. This page tracks Pharmena S.A.'s live share price on the WAR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PHR stock market capitalisation.

Pharmena S.A. (PHR) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Pharmena S.A.'s daily closing share price and trading volume on the WAR exchange over the past year, giving a clear view of recent price momentum and liquidity.

Pharmena S.A. Income Statement — Revenue, Profit & Earnings by Year

Pharmena S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue zł268.00K zł9.84 Million zł299.00K zł15.21 Million zł9.93 Million
Cost of Revenue zł70.00K zł3.99 Million zł8.69 Million zł7.38 Million zł4.85 Million
Gross Profit zł198.00K zł5.84 Million zł10.34 Million zł7.83 Million zł5.08 Million
Research & Development zł10.00K zł153.00K zł133.00K
SG&A zł2.95 Million zł3.59 Million zł3.23 Million zł4.68 Million zł3.98 Million
Total Operating Expenses zł3.60 Million zł-29.03 Million zł10.85 Million zł11.84 Million zł11.12 Million
Operating Income zł-3.40 Million zł34.87 Million zł-508.00K zł-3.98 Million zł-6.04 Million
EBITDA zł-3.38 Million zł35.55 Million zł-129.00K zł-3.52 Million zł-5.40 Million
EBIT zł-3.40 Million zł35.23 Million zł-690.00K zł-4.14 Million zł-6.03 Million
Interest Expense zł530.00K zł722.00K zł265.00K zł204.00K
Income Before Tax zł-2.56 Million zł34.86 Million zł-4.95 Million zł-4.46 Million zł-6.27 Million
Income Tax Expense zł-1.29 Million zł5.91 Million zł204.00K zł182.00K zł686.00K
Net Income zł-1.26 Million zł28.94 Million zł-1.57 Million zł-4.59 Million zł-6.89 Million

Pharmena S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Pharmena S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets zł13.53 Million zł24.13 Million zł12.58 Million zł11.15 Million zł10.95 Million
Total Current Assets zł11.88 Million zł23.33 Million zł9.97 Million zł8.20 Million zł8.26 Million
Cash & Equivalents
Short-term Investments zł380.00K
Net Receivables zł76.00K zł305.00K zł3.81 Million zł3.20 Million zł2.41 Million
Inventory zł689.00K zł445.00K zł4.56 Million zł3.46 Million zł4.00 Million
Property, Plant & Equipment zł498.00K zł808.00K zł435.00K
Goodwill
Total Liabilities zł1.11 Million zł1.91 Million zł19.37 Million zł16.27 Million zł11.30 Million
Total Current Liabilities zł915.00K zł1.77 Million zł16.97 Million zł11.58 Million zł11.13 Million
Long-term Debt zł137.00K
Net Debt zł-1.50 Million zł-22.06 Million zł-1.08 Million zł-678.00K zł-1.33 Million
Total Stockholder Equity zł12.42 Million zł22.52 Million zł-6.49 Million zł-4.87 Million zł-139.00K
Retained Earnings zł-1.26 Million zł-22.99 Million zł-51.93 Million zł-50.36 Million zł-56.15 Million

Pharmena S.A. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Pharmena S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow zł-2.53 Million zł33.03 Million zł1.82 Million zł-3.23 Million zł-2.24 Million
Capital Expenditures zł180.00K zł314.00K zł226.00K zł319.00K zł214.00K
Free Cash Flow zł-2.71 Million zł32.72 Million zł1.59 Million zł-3.54 Million zł-2.46 Million
Investing Cash Flow zł-8.36 Million zł-3.13 Million zł-219.00K zł-248.00K zł-198.00K
Financing Cash Flow zł-9.54 Million zł-9.26 Million zł-1.47 Million zł3.21 Million zł3.12 Million
Dividends Paid zł9.47 Million
Stock-Based Compensation
Depreciation zł95.00K zł325.00K zł561.00K zł626.00K zł628.00K
Change in Cash zł-20.49 Million zł20.64 Million zł132.00K zł-262.00K zł674.00K

Pharmena S.A. Earnings History — EPS Actual vs. Analyst Estimates

Track Pharmena S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 25, 2026
Mar 30, 2026
Nov 24, 2025
Aug 25, 2025
May 26, 2025
Feb 26, 2025
Nov 25, 2024 -0.04
Aug 26, 2024 -0.08